Analyst Daina Graybosch works at LEERINK and is focused on the Healthcare sector with 208 price targets and ratings documented since 2019 spanning on 18 stocks. Analyst's average stock valuation to be materialised ratio is 31.5% with an average time for price targets to be met of 117.12 days.
Most recent stock forecast was given on MRK, Merck & Co., Inc at 03-Feb-2023.
Daina Graybosch best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS INC).
The best stock recommendation documented was for SBTX (SILVERBACK THERAPEUTICS INC) at 12/29/2020. The price target of $40 was fulfilled within 1 day with a profit of $3 (8.11%) receiving and performance score of 81.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
37
$3.63 (10.88%)
24
1 months 24 days ago
1/2 (50%)
$6.41 (30.62%)
100
Buy
38
$4.63 (13.87%)
25
1 months 25 days ago
1/2 (50%)
$8.89 (41.47%)
282
Buy
35
$1.63 (4.88%)
31
1 months 25 days ago
1/2 (50%)
$8.54 (37.34%)
47
Buy
34
$0.63 (1.89%)
32
1 months 25 days ago
1/2 (50%)
$8.59 (38.43%)
147
